Condition
Malignant Pleural Mesothelioma clinical trials and research
Research outlook What's coming for Mesothelioma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Malignant Pleural Mesothelioma clinical trials that are recruiting, at sites in 5 countries (most in Belgium (1), United Kingdom (1), China (1)). By phase: Phase 1/2 (1), Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Malignant Pleural Mesothelioma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Measuring treatment response in malignant pleural mesothelioma using breathprinting technology | — | Basking Ridge, New Jersey and 6 other locations | Recruiting | Sep 14, 2023 |
| Combining a PD-L1 inhibitor and dendritic cell vaccination with chemotherapy for malignant pleural mesothelioma | Phase 1/2 | Edegem, Antwerp and 2 other locations | Recruiting | Mar 13, 2023 |
| Proton therapy for treating malignant pleural mesothelioma | — | Eastbourne, East Sussex and 24 other locations | Recruiting | Dec 16, 2022 |
| Innovative treatment combining photodynamic therapy and immunotherapy for malignant pleural mesothelioma | Phase 2 | Lille | Recruiting | May 22, 2020 |
| APG-2449 for advanced solid tumors | Phase 1 | Beijing, Beijing Municipality and 8 other locations | Recruiting | Apr 16, 2019 |
All recruiting trials (5)
-
Measuring treatment response in malignant pleural mesothelioma using breathprinting technology
This study is testing if a special breath-sensing device can help track how well treatment is working for people with malignant pleural mesothelioma.
-
Combining a PD-L1 inhibitor and dendritic cell vaccination with chemotherapy for malignant pleural mesothelioma
This study is testing a new treatment that combines a PD-L1 blocker and a special vaccine with chemotherapy to see if it helps people with a type of lung cancer called malignant pleural mesothelioma.
-
Proton therapy for treating malignant pleural mesothelioma
This study is testing if proton therapy can help people with malignant pleural mesothelioma live longer and feel better compared to standard care.
-
Innovative treatment combining photodynamic therapy and immunotherapy for malignant pleural mesothelioma
This study is testing a new treatment that combines light therapy and immune therapy to see if it can help patients with advanced malignant pleural mesothelioma who haven't responded well to chemotherapy.
-
APG-2449 for advanced solid tumors
This study is testing a new oral medication called APG-2449 to see how well it works and what the safe dosage is for people with advanced solid tumors like non-small cell lung cancer.
Related topics
Quick answers
How many Malignant Pleural Mesothelioma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Belgium (1 trial), United Kingdom (1 trial), China (1 trial), France (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.